RECOVERY OF RENAL FUNCTION AND PROGNOSIS
OF AKI IN THE ELDERLY
A recent systematic review and meta-analysis of recovery of
kidney function after AKI in the elderly has shown that recov-
ery after AKI is approximately 28% less likely to occur when
the patient is older than 65 yr.
24
Whether these results are
caused by the effects of advanced age on the kidney itself or the
increased number of comorbidities (including baseline CKD)
in the elderly is not certain. Long-term recovery is also less
likely and it is believed that AKI in elderly more often results in
CKD.
24
The lower likelihood of renal recovery in the elderly
may be due to the effects of aging to impair the capacity for
kidney repair.
25
The capacity for renal epithelial cell prolifera-
tion declines with aging as does the function of progenitor and
stem cells that are critical for tubular repair.
25
Several other individual studies have not been able to show
that age is specifically associated with impaired renal recov-
ery.
18
Thus, in the individual patient, it may not be clear if age
is an independent predictor of a poor prognosis and other
comorbid conditions may play a more important role in driv-
ing the risk for poor outcomes.
26
CONCLUSIONS
For numerous reasons, elderly patients are at higher risk for the
development of AKI, and certain causes of AKI are more com-
monly seen in this group. In fact, there are more often multiple
etiologies of AKI in this age group. Diagnostic approaches to
AKI should focus on the most likely etiologies. Because of mul-
tiple factors, the likelihood of complete renal recovery is im-
paired in this group.
TAKE HOME POINTS
• Elderly patients are at higher risk for the development of AKI
• Specific hemodynamic, metabolic, and molecular changes lead to in-
creased susceptibility to injury in the aged kidney
• Certain causes of AKI are more common in the elderly: postrenal
obstructive disease, ischemic ATN, and hemodynamically mediated
AKI
• Multiple etiologies are often operative in the development of AKI
• Diagnostic and therapeutic issues in AKI are no different for the elderly
patient as for the general population
• The outlook for renal recovery is likely impaired in the elderly patient
DISCLOSURES
None.
REFERENCES
*Key References
1. Feest TJ, Round A, Hamad S: Incidence of severe acute renal failure in
adults: results of a community-based study. BMJ 306: 481– 483, 1993*
2. Turney JH, Marshall DH, Brownjohn AM, Ellis CM, Parsons FM: The
evolution of acute renal failure. QJM 74: 83–104, 1990
3. Groeneveld AB, Tran DD, van der Meulen J, Nauta JJ, Thijs LG: Acute
renal failure in the intensive care unit: predisposing, complicating
factors affecting outcome. Nephron 59: 602–610, 1991
4. Macı´as-Nu´n˜ ez JF, Lo´ pez-Novoa JM, Martı´nez-Maldonado M: Acute
renal failure in the aged. Semin Nephrol 16: 330–338, 1996*
5. Choudhury DRD, Levi M: Effect of aging on renal function ad disease.
In: Brenner and Rector’s The Kidney, 7th Ed., edited by Brenner B,
Philadelphia, PA, Saunders, 2004, pp 2305–2315
6. Esposito C, Plati A, Mazzullo T, Fasoli G, De Mauri A, Grosjean F,
Mangione F, Castoldi F, Serpieri N, Cornacchia F, Dal Canton A: Renal
function and functional reserve in healthy elderly individuals. J Neph-
rol 20: 617– 625, 2007*
7. Vercauteren SR, Ysebaert DK, De Greef KE, Eyskens EJ, De Broe ME:
Chronic reduction in renal mass in the rat attenuates ischemia/reper-
fusion injury and does not impair tubular regeneration. JAmSoc
Nephrol 10: 2551–2561, 1999*
8. Lameire N, Hoste E, Van Loo A, Dhondt A, Bernaert P, Vanholder R:
Pathophysiology, causes and prognosis of acute renal failure in the
elderly. Ren Fail 18: 333–346, 1996*
9. Reckelhoff JF, Manning RD: Role of endothelium-derived nitric oxide
in control of renal microvasculature in aging male rats. Am J Physiol
265(Suppl): R1123–R1129, 1993
10. Rivas-Caban˜ ero L, Rodriguez-Barbero A, Are´valo M, Lo´ pez-Novoa JM:
Effect of Ng-nitro-L-arginine methyl ester on gentamicin-induced
nephrotoxicity in rats. Nephron 71: 203–207, 1995
11. Miura K, Goldstein RS, Morgan DG, Pasino DA, Hewitt WR, Hook JB:
Age-related differences in susceptibility to renal ischemia in rats.
Toxicol Appl Pharmacol 87: 284 –296, 1987
12. Cheung CM, Ponnusamy A, Anderton JG: Management of acute renal
failure in the elderly patient: a clinician’s guide. Drugs Aging 25:
455–476, 2008
13. Lavizzo-Mourey R, Johnson J, Stolley P: Risk factors for dehydration
1988
14. Weinberg AD, Pals JK, Levesque PG, Beal LF, Cunningham TJ, Mi-
naker KL: Dehydration and death during febrile episodes in the nurs-
ing home. J Am Geriatr Soc 42: 968 –971, 1994
15. Blackshear JL, Davidman M, Stillman MT: Identification of risk for renal
Table 2. Examples of specific renal protective strategies
Exposure Strategy
Radiocontrast agents Intravenous hydration (normal saline)
Intravenous sodium bicarbonate (?)
N-acetylcysteine
Vitamin C
Iso-osmolar contrast
Aminoglycoside
antibiotics
Once-daily dosing
Monitoring of drug levels
Tumor lysis (uric acid) Allopurinol/rasburicase
Intravenous hydration/urine alkalinization
Ethylene glycol
ingestion
Ethanol/fomepizole
Hemodialysis
Rhabdomyolysis Intravenous hydration/urine alkalinization⫾
mannitol
Methotrexate Intravenous hydration/urine alkalinization
Acyclovir Intravenous hydration
Calcineurin inhibitors Monitor drug levels ⫾ calcium-channel
blockers
Amphotericin B Use of lipid formulation
4 Geriatric Nephrology Curriculum American Society of Nephrology